Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Mideco Pharm
- ·The full record, as it builds
Funding rounds
No funding rounds for Mideco Pharm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mideco Pharm
Developer of pharmaceutical ingredients and functional small molecules intended to support drug development, manufacturing, and supply across global pharmaceutical markets. The company offers integrated R&D and production capabilities, strong technical expertise, and compliance with international quality standards, enabling pharmaceutical manufacturers and research organizations to access reliable, high-quality raw materials and customized manufacturing support.
- Sector
- Healthcare
- HQ
- Chongqing, China
- Founded
- 2018
- Website
- midecopharm.com/
- Ownership
- Privately Held (backing)
Mideco Pharm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mideco Pharm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mideco Pharm in its N-PORT filings yet. We sweep new filings monthly.